Clinical Chair Professor Henning Gronbaek

All Stories

1. 
   Gut microbiota-derived imidazole propionate promotes primary sclerosing cholangitis via p38 signalling

   Article • Nature Metabolism, September 2026, Springer Science + Business Media

   Clinical Chair Professor Henning Gronbaek

2. 
   Proof-of-Concept Study of Hyperpolarized [1- 13 C]Pyruvate MRI in Participants with Hepatocellular Carcinoma

   Article • Radiology Imaging Cancer, September 2026, Radiological Society of North America (RSNA)

   Clinical Chair Professor Henning Gronbaek

3. 
   Gene‐Based Clustering Identifies QSOX1 and IL1RAP as Biomarkers of Metabolic Dysfunction‐Associated Steatotic Liver Disease

   Article • Liver International, July 2026, Wiley

   Clinical Chair Professor Henning Gronbaek

4. 
   Development and validation of the A-TANGO organ failure score for acute-on-chronic liver failure in global cohorts

   Article • Journal of Hepatology, July 2026, Elsevier

   Clinical Chair Professor Henning Gronbaek

5. 
   Molecular Quantification of Fibrogenesis and Macrophage Activation Associate With Clinical Worsening in Patients With Cirrhosis

   Article • Liver International Communications, April 2026, Wiley

   Clinical Chair Professor Henning Gronbaek

6. 
   Primary Biliary Cholangitis Increases Mortality Irrespective of Presence or Absence of Cirrhosis

   Article • Liver International, March 2026, Wiley

   Clinical Chair Professor Henning Gronbaek

7. 
   Biomarker‐directed aptamer panels for diagnosis and differentiation of neuroendocrine tumors

   Article • Journal of Neuroendocrinology, February 2026, Wiley

   Clinical Chair Professor Henning Gronbaek

8. 
   Quality of Life in Patients With Variant Syndromes of Autoimmune Liver Diseases—A Cross‐Sectional Multicentre Study

   Article • Liver International, February 2026, Wiley

   Clinical Chair Professor Henning Gronbaek

9. 
   Viral Hepatitis B, C and Delta in Greenland: A National Cross‐Sectional Study

   Article • Journal of Viral Hepatitis, January 2026, Wiley

   Clinical Chair Professor Henning Gronbaek

10. 
    Soluble CD163 as a Biomarker of Liver Fibrosis and Inflammation in Liver Transplant Recipients

    Article • Clinical Transplantation, January 2026, Wiley

    Clinical Chair Professor Henning Gronbaek

11. 
    Awareness of Primary Biliary Cholangitis Among Turkish Physicians: A Cross-Sectional, Multicenter, Web-Based Survey

    Article • Journal of Clinical Medicine, January 2026, MDPI AG

    Clinical Chair Professor Henning Gronbaek

12. 
    Quality of Life in Patients With Primary Sclerosing Cholangitis

    Article • Gastro Hep Advances, January 2026, Elsevier

    Clinical Chair Professor Henning Gronbaek

13. 
    Association between quality of life and inflammation and fibrosis markers in primary biliary cholangitis over three-year follow-up

    Article • Scandinavian Journal of Gastroenterology, December 2025, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

14. 
    A Phase 2a Trial of Myeloperoxidase Inhibitor Mitiperstat in Non‐Cirrhotic Metabolic Dysfunction‐Associated Steatohepatitis

    Article • Liver International, October 2025, Wiley

    Clinical Chair Professor Henning Gronbaek

15. 
    Proteomic signatures reflect effects of semaglutide treatment for MASH

    Article • JHEP Reports, October 2025, Elsevier

    Clinical Chair Professor Henning Gronbaek

16. 
    Association rule mining of clinical and biomarker data in neuroendocrine tumors: A prospective study on disease progression

    Article • Journal of Neuroendocrinology, August 2025, Wiley

    Clinical Chair Professor Henning Gronbaek

17. 
    Fibrosis markers as prognostic markers of decline in kidney function in patients with neuroendocrine neoplasms undergoing peptide receptor radionuclide therapy

    Article • Frontiers in Endocrinology, June 2025, Frontiers

    Clinical Chair Professor Henning Gronbaek

18. 
    Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, June 2025, New England Journal of Medicine (NEJM/MMS)

    Clinical Chair Professor Henning Gronbaek

19. 
    Anti‐Ro52/TRIM21 autoantibodies predict Sjögren's syndrome in patients with primary biliary cholangitis

    Article • Hepatology Research, May 2025, Wiley

    Clinical Chair Professor Henning Gronbaek

20. 
    Hepatocellular adenomas

    Article • Ugeskrift for Læger, April 2025, Danish Medical Association

    Clinical Chair Professor Henning Gronbaek

21. 
    Elevated Liver Enzymes in Turner Syndrome: The Role of Low-grade Inflammation and Hormonal Imbalances

    Article • Journal of the Endocrine Society, April 2025, Endocrine Society

    Clinical Chair Professor Henning Gronbaek

22. 
    The promise of incretin-based pharmacotherapies for metabolic dysfunction-associated fatty liver disease

    Article • Hepatology International, March 2025, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

23. 
    Gene score to quantify systemic inflammation in patients with acutely decompensated cirrhosis

    Article • Gut, February 2025, BMJ

    Clinical Chair Professor Henning Gronbaek

24. 
    Health-related quality of life is impaired in people with autoimmune hepatitis: Results of a multicentre cross-sectional study within the European Reference Network

    Article • Hepatology, February 2025, Wolters Kluwer Health

    Clinical Chair Professor Henning Gronbaek

25. 
    Diagnosis and Staging of Metabolic Dysfunction-Associated Steatotic Liver Disease Using Biomarker-Directed Aptamer Panels

    Article • Biomolecules, February 2025, MDPI AG

    Clinical Chair Professor Henning Gronbaek

26. 
    Clinical and Biochemical Characteristics of a Danish and Turkish Cohort of Incident and Prevalent Patients with Primary Biliary Cholangitis

    Article • The Turkish Journal of Gastroenterology, January 2025, AVES Publishing Co.

    Clinical Chair Professor Henning Gronbaek

27. 
    Christmas article: Importance of seniority and daily variation for the flattening of academic medical language

    Article • Ugeskrift for Læger, December 2024, Danish Medical Association

    Clinical Chair Professor Henning Gronbaek

28. 
    NAFLD to MAFLD: collaboration, not confusion - rethinking the naming of fatty liver disease

    Article • Metabolism and Target Organ Damage, December 2024, OAE Publishing

    Clinical Chair Professor Henning Gronbaek

29. 
    Comparable glucagon-stimulated amino acid suppression in individuals with and without hepatic steatosis or steatohepatitis

    Article • AJP Endocrinology and Metabolism, December 2024, American Physiological Society

    Clinical Chair Professor Henning Gronbaek

30. 
    Alteration of the Gut–Lung Axis After Severe COVID-19 Infection and Modulation Through Probiotics: A Randomized, Controlled Pilot Study

    Article • Nutrients, November 2024, MDPI AG

    Clinical Chair Professor Henning Gronbaek

31. 
    A potential novel stratification model to predict cardiovascular disease in patients with metabolic dysfunction-associated steatotic liver disease

    Article • European Journal of Internal Medicine, November 2024, Elsevier

    Clinical Chair Professor Henning Gronbaek

32. 
    CEUS compared with CECT, MRI, and FDG-PET/CT for diagnosing CRC liver metastases: a diagnostic test accuracy systematic review and meta-analysis

    Article • Expert Review of Gastroenterology & Hepatology, September 2024, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

33. 
    CTX‐III in hepatitis C

    Article • Liver International, August 2024, Wiley

    Clinical Chair Professor Henning Gronbaek

34. 
    The effect of twin pregnancy in intrahepatic cholestasis of pregnancy: A case control study

    Article • Acta Obstetricia Et Gynecologica Scandinavica, July 2024, Wiley

    Clinical Chair Professor Henning Gronbaek

35. 
    Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact

    Article • Hepatology International, July 2024, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

36. 
    Similar insulin regulation of splanchnic FFA and VLDL-TG in men with nonalcoholic hepatic steatosis and steatohepatitis

    Article • Journal of Lipid Research, July 2024, Elsevier

    Clinical Chair Professor Henning Gronbaek

37. 
    Randomized clinical trial on safety of the natriuretic peptide ularitide as treatment of refractory cirrhotic ascites

    Article • Hepatology Communications, June 2024, Wolters Kluwer Health

    Clinical Chair Professor Henning Gronbaek

38. 
    A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease

    Article • Hepatology International, June 2024, Springer Science + Business Media

    Dr Benjamin Mullish, Dr. Federico Ravaioli, Clinical Chair Professor Henning Gronbaek

39. 
    New nomenclature for fatty liver disease

    Article • Ugeskrift for Læger, May 2024, Danish Medical Association

    Clinical Chair Professor Henning Gronbaek

40. 
    Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature

    Article • Journal of Hepatology, May 2024, Elsevier

    Clinical Chair Professor Henning Gronbaek, Professor Amedeo LONARDO

41. 
    Societal costs and survival of patients with biopsy-verified non-alcoholic steatohepatitis: Danish nationwide register-based study

    Article • Annals of Hepatology, May 2024, Elsevier

    Clinical Chair Professor Henning Gronbaek

42. 
    Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease

    Article • European Journal of Internal Medicine, April 2024, Elsevier

    Clinical Chair Professor Henning Gronbaek

43. 
    Effects of Peptide Receptor Radiotherapy in Patients with Advanced Paraganglioma and Pheochromocytoma: A Nation-Wide Cohort Study

    Article • Cancers, March 2024, MDPI AG

    Clinical Chair Professor Henning Gronbaek

44. 
    High-dose oral thiamine versus placebo for chronic fatigue in patients with primary biliary cholangitis: A crossover randomized clinical trial

    Article • PLOS One, March 2024, PLOS

    Clinical Chair Professor Henning Gronbaek

45. 
    Dosimetry and pharmacokinetics of [177Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours

    Article • European Journal of Pediatrics, March 2024, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

46. 
    The prevalence and disease course of autoimmune liver diseases in Greenland

    Article • International Journal of Circumpolar Health, March 2024, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

47. 
    The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement

    Article • Hepatology Communications, February 2024, Wolters Kluwer Health

    Clinical Chair Professor Henning Gronbaek

48. 
    Hepatocellular carcinoma in autoimmune hepatitis remains rare

    Article • Journal of Hepatology, January 2024, Elsevier

    Clinical Chair Professor Henning Gronbaek

49. 
    Predicting survival in patients with ‘non-high-risk’ acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding

    Article • Journal of Hepatology, January 2024, Elsevier

    Clinical Chair Professor Henning Gronbaek

50. 
    Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial

    Article • Hepatology Communications, December 2023, Wolters Kluwer Health

    Clinical Chair Professor Henning Gronbaek

51. 
    The vascular endothelial growth factor system—a new player in the pathogenesis and development of metabolic dysfunction- associated steatotic liver disease

    Article • HepatoBiliary Surgery and Nutrition, December 2023, AME Publishing Company

    Clinical Chair Professor Henning Gronbaek

52. 
    Unveiling the pathogenesis of non-alcoholic fatty liver disease by decoding biomarkers through integrated single-cell and single-nucleus profiles

    Article • October 2023, openRxiv

    Clinical Chair Professor Henning Gronbaek

53. 
    Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysis

    Article • Hepatology, October 2023, Wolters Kluwer Health

    Clinical Chair Professor Henning Gronbaek

54. 
    Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing cholangitis before and after liver transplantation

    Article • Journal of Hepatology, October 2023, Elsevier

    Clinical Chair Professor Henning Gronbaek

55. 
    A phase I/II study of the safety and efficacy of [177Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumours

    Article • European Journal of Pediatrics, September 2023, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

56. 
    The role of N‐terminal pro‐brain natriuretic peptide, chromogranin A, and 5‐hydroxyindoleacetic acid in screening for carcinoid heart disease

    Article • Journal of Neuroendocrinology, August 2023, Wiley

    Clinical Chair Professor Henning Gronbaek

57. 
    A global action agenda for turning the tide on fatty liver disease

    Article • Hepatology, August 2023, Wolters Kluwer Health

    Professor Yousef Khader, Dr Amalia Gastaldelli, Clinical Chair Professor Henning Gronbaek

58. 
    A gene-based clustering approach reveals QSOX1/IL1RAP as promising biomarkers for the severity of non-alcoholic fatty liver disease

    Article • July 2023, openRxiv

    Clinical Chair Professor Henning Gronbaek

59. 
    Serum interleukin-4 is elevated in clinical drug-induced liver injury

    Article • Scandinavian Journal of Gastroenterology, July 2023, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

60. 
    Fungal translocation measured by serum 1,3‐ß‐D‐glucan correlates with severity and outcome of liver cirrhosis—A pilot study

    Article • Liver International, June 2023, Wiley

    Clinical Chair Professor Henning Gronbaek

61. 
    Editorial: non‐invasive diagnosis of alcohol‐related steatohepatitis in patients ongoing alcohol withdrawal based on cytokeratin 18 and transient elastography

    Article • Alimentary Pharmacology & Therapeutics, June 2023, Wiley

    Clinical Chair Professor Henning Gronbaek

62. 
    A nationwide study of autoimmune liver diseases in the Faroe Islands: Incidence, prevalence, and causes of death 2004 - 2021

    Article • International Journal of Circumpolar Health, June 2023, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

63. 
    A global research priority agenda to advance public health responses to fatty liver disease

    Article • Journal of Hepatology, June 2023, Elsevier

    Dr Mona H. Ismail, Professor Yousef Khader, Dr Amalia Gastaldelli, Clinical Chair Professor Henning Gronbaek

64. 
    Soluble CD163 as a biomarker of liver fibrosis in liver transplant recipients

    Article • Journal of Hepatology, June 2023, Elsevier

    Clinical Chair Professor Henning Gronbaek

65. 
    Alcohol‐related liver disease phenotype impacts survival after an acute variceal bleeding episode

    Article • Liver International, May 2023, Wiley

    Clinical Chair Professor Henning Gronbaek

66. 
    Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms

    Article • Acta Oncologica, May 2023, Acta Dermato-Venereologica

    Clinical Chair Professor Henning Gronbaek

67. 
    Exercise increases myocardial free fatty acid oxidation in subjects with metabolic dysfunction-associated fatty liver disease

    Article • Atherosclerosis, May 2023, Elsevier

    Clinical Chair Professor Henning Gronbaek, Dr Mogens Johannsen

68. 
    The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis

    Article • Hepatology Communications, March 2023, Wolters Kluwer Health

    Clinical Chair Professor Henning Gronbaek

69. 
    The macrophage activation marker sCD163 in acute and chronic graft-versus-host disease after pediatric hematopoietic stem cell transplantation

    Article • British Journal of Pharmacology, January 2023, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

70. 
    The Prevalence of Inflammatory Bowel Disease in Greenland

    Article • Inflammatory Bowel Diseases, January 2023, Oxford University Press (OUP)

    Clinical Chair Professor Henning Gronbaek

71. 
    Current paradigm and treatment options for autoimmune hepatitis

    Article • January 2023, Elsevier

    Clinical Chair Professor Henning Gronbaek

72. 
    Effects of lifestyle intervention on IGF-1, IGFBP-3, and insulin resistance in children with obesity with or without metabolic-associated fatty liver disease

    Article • European Journal of Pediatrics, December 2022, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

73. 
    Association between fibrosis markers and kidney function following peptide receptor radionuclide therapy in patients with neuroendocrine tumours

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, September 2022, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

74. 
    Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding

    Article • Gut, September 2022, BMJ

    Clinical Chair Professor Henning Gronbaek

75. 
    Impaired Glucagon-Mediated Suppression of VLDL-Triglyceride Secretion in Individuals With Metabolic Dysfunction–Associated Fatty Liver Disease (MAFLD)

    Article • Diabetes, August 2022, American Diabetes Association

    Clinical Chair Professor Henning Gronbaek

76. 
    Development and validation of the Cirrhotic Ascites Severity model—A patient‐reported outcome‐based model to predict 1‐year mortality

    Article • Hepatology Communications, August 2022, Wolters Kluwer Health

    Clinical Chair Professor Henning Gronbaek

77. 
    Spotlight on liver macrophages for halting injury and progression in nonalcoholic fatty liver disease

    Article • Expert Opinion on Therapeutic Targets, August 2022, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

78. 
    von Hippel-Lindau disease: Updated guideline for diagnosis and surveillance

    Article • European Journal of Medical Genetics, August 2022, Elsevier

    Clinical Chair Professor Henning Gronbaek

79. 
    Fatigue and quality of life in patients with neuroendocrine neoplasia

    Article • Scandinavian Journal of Gastroenterology, July 2022, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

80. 
    Predicting Progression, Recurrence, and Survival in Pancreatic Neuroendocrine Tumors: A Single Center Analysis of 174 Patients

    Article • Frontiers in Endocrinology, June 2022, Frontiers

    Clinical Chair Professor Henning Gronbaek

81. 
    The presence of interferon affects the progression of non-alcoholic fatty liver disease

    Article • Genes & Immunity, June 2022, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

82. 
    Plasma protein biomarkers for the detection of pancreatic neuroendocrine tumours and differentiation from small intestinal neuroendocrine tumours

    Article • Journal of Neuroendocrinology, June 2022, Wiley

    Clinical Chair Professor Henning Gronbaek

83. 
    276-OR: Impaired Glucagon-Mediated Suppression of VLDL-TG Secretion in Individuals with MAFLD

    Article • Diabetes, June 2022, American Diabetes Association

    Clinical Chair Professor Henning Gronbaek

84. 
    Global multi-stakeholder endorsement of the MAFLD definition

    Article • The Lancet Gastroenterology & Hepatology, May 2022, Elsevier

    Dr Feliciano C Paquissi, Professor Sandro Vento, Dr. Francesca Cainelli, Prof. Dr. Mahmoud ElFiky, Dr Arif Mansur Cosar, Dr Amalia Gastaldelli, Dr Nazarii Kobyliak, Prof james O'Beirne, Clinical Chair Professor Henning Gronbaek

85. 
    Effects and safety of natriuretic peptides as treatment of cirrhotic ascites: A systematic review and meta-analysis

    Article • World Journal of Hepatology, April 2022, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Clinical Chair Professor Henning Gronbaek

86. 
    Non-alcoholic fatty liver disease in patients with type 2 diabetes in Greenland: a register-based cross-sectional study

    Article • International Journal of Circumpolar Health, April 2022, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

87. 
    Clinical Progression of Metabolic-Associated Fatty Liver Disease Is Rare in a Danish Tertiary Liver Center

    Article • Journal of Clinical Medicine, April 2022, MDPI AG

    Clinical Chair Professor Henning Gronbaek

88. 
    Highly Increased Levels of Inter-α-inhibitor Heavy Chain 4 (ITIH4) in Autoimmune Cholestatic Liver Diseases

    Article • Journal of Clinical and Translational Hepatology, March 2022, Xia & He Publishing

    Clinical Chair Professor Henning Gronbaek

89. 
    The NAFLD‐MAFLD debate: Is there a Consensus‐on‐Consensus methodology?

    Article • Liver International, February 2022, Wiley

    Clinical Chair Professor Henning Gronbaek

90. 
    The galactose elimination capacity test to monitor liver disease course in patients with Wilson’s disease

    Article • Scandinavian Journal of Gastroenterology, January 2022, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

91. 
    Contacts to general practice in the 12 months preceding a diagnosis of an abdominal cancer: a national register-based cohort study

    Article • Scandinavian Journal of Primary Health Care, January 2022, Taylor & Francis

    Clinical Chair Professor Henning Gronbaek

92. 
    Prognosis of Patients with Bronchopulmonary Neuroendocrine Neoplasms in a Tertiary Neuroendocrine Tumor Centre of Excellence

    Article • Neuroendocrinology, January 2022, Karger Publishers

    Clinical Chair Professor Henning Gronbaek

93. 
    Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux‐en‐Y gastric bypass

    Article • Physiological Reports, January 2022, Wiley

    Clinical Chair Professor Henning Gronbaek

94. 
    Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure

    Article • JHEP Reports, December 2021, Elsevier

    Clinical Chair Professor Henning Gronbaek

95. 
    Advancing the global public health agenda for NAFLD: a consensus statement

    Article • Nature Reviews Gastroenterology & Hepatology, October 2021, Springer Science + Business Media

    Professor Yousef Khader, Clinical Chair Professor Henning Gronbaek

96. 
    A novel read methodology to evaluate the optimal dose of 68Ga-satoreotide trizoxetan as a PET imaging agent in patients with gastroenteropancreatic neuroendocrine tumours: a phase II clinical trial

    Article • EJNMMI Research, September 2021, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

97. 
    Metformin Stimulates Intestinal Glycolysis and Lactate Release: A single‐Dose Study of Metformin in Patients With Intrahepatic Portosystemic Stent

    Article • Clinical Pharmacology & Therapeutics, August 2021, Wiley

    Clinical Chair Professor Henning Gronbaek

98. 
    Cognitive impairment in stable Wilson disease across phenotype

    Article • Metabolic Brain Disease, August 2021, Springer Science + Business Media

    Clinical Chair Professor Henning Gronbaek

99. 
    Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis

    Article • Journal of Hepatology, August 2021, Elsevier

    Clinical Chair Professor Henning Gronbaek

100. 
     Editorial: metformin for portal hypertension—old dog, new tricks? Authors' reply

     Article • Alimentary Pharmacology & Therapeutics, July 2021, Wiley

     Clinical Chair Professor Henning Gronbaek

101. 
     A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for 68Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors

     Article • Journal of Nuclear Medicine, July 2021, Society of Nuclear Medicine

     Clinical Chair Professor Henning Gronbaek

102. 
     Metabolic effects of 1-week binge drinking and fast food intake during Roskilde Festival in young healthy male adults

     Article • European Journal of Endocrinology, July 2021, Oxford University Press (OUP)

     Clinical Chair Professor Henning Gronbaek

103. 
     Randomised clinical study: acute effects of metformin versus placebo on portal pressure in patients with cirrhosis and portal hypertension

     Article • Alimentary Pharmacology & Therapeutics, June 2021, Wiley

     Clinical Chair Professor Henning Gronbaek

104. 
     Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension

     Article • Frontiers in Physiology, June 2021, Frontiers

     Clinical Chair Professor Henning Gronbaek

105. 
     Abdominal investigations in the year preceding a diagnosis of abdominal cancer: A register-based cohort study in Denmark

     Article • Cancer Epidemiology, June 2021, Elsevier

     Clinical Chair Professor Henning Gronbaek

106. 
     Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

     Article • Acta Oncologica, May 2021, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

107. 
     Cognitive Impairment In Stable Wilson Disease Across Phenotype.

     Article • May 2021, Research Square

     Clinical Chair Professor Henning Gronbaek

108. 
     Core liver homeostatic co-expression networks are preserved but respond to perturbations in an organism- and disease-specific manner

     Article • Cell Systems, May 2021, Elsevier

     Clinical Chair Professor Henning Gronbaek

109. 
     PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

     Article • Journal of Hepatology, May 2021, Elsevier

     Clinical Chair Professor Henning Gronbaek, Dr Maurizio Baldassarre

110. 
     P316 Human neutrophil elastase derived fragment of calprotectin (S100a9) is a serum biomarker (CPa9-HNE) for monitoring of anti-TNFα treatment response in Crohn’s disease

     Article • Journal of Crohn s and Colitis, May 2021, Oxford University Press (OUP)

     Clinical Chair Professor Henning Gronbaek

111. 
     Cancer suspicion, referral to cancer patient pathway and primary care interval: a survey and register study exploring 10 different types of abdominal cancer

     Article • Family Practice, April 2021, Oxford University Press (OUP)

     Clinical Chair Professor Henning Gronbaek

112. 
     Combining tissue and circulating tumor DNA increases the detection rate of a CTNNB1 mutation in hepatocellular carcinoma

     Article • BMC Cancer, April 2021, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

113. 
     A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

     Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, March 2021, New England Journal of Medicine (NEJM/MMS)

     Clinical Chair Professor Henning Gronbaek

114. 
     Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis

     Article • Clinical and Translational Gastroenterology, March 2021, Wolters Kluwer Health

     Clinical Chair Professor Henning Gronbaek

115. 
     Interferon lambda 4 genotype and pathway in alcoholic hepatitis

     Article • Scandinavian Journal of Gastroenterology, February 2021, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

116. 
     Efficacy of Dietary Manipulations for Depleting Intrahepatic Triglyceride Content: Implications for the Management of Non-alcoholic Fatty Liver Disease

     Article • Current Obesity Reports, February 2021, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek, Professor Maria Dalamaga

117. 
     Increased occurrence of liver and gastrointestinal diseases and anaemia in women with Turner syndrome – a nationwide cohort study

     Article • Alimentary Pharmacology & Therapeutics, February 2021, Wiley

     Clinical Chair Professor Henning Gronbaek

118. 
     No Effect in Alcoholic Hepatitis of Gut-Selective, Broad-Spectrum Antibiotics on Bacterial Translocation or Hepatic and Systemic Inflammation

     Article • Clinical and Translational Gastroenterology, January 2021, Wolters Kluwer Health

     Clinical Chair Professor Henning Gronbaek

119. 
     Administrative coding in electronic health care record‐based research of NAFLD: an expert panel consensus statement

     Article • Hepatology, January 2021, Wiley

     Clinical Chair Professor Henning Gronbaek

120. 
     Clinical efficacy of first and second series of peptide receptor radionuclide therapy in patients with neuroendocrine neoplasm: a cohort study

     Article • Scandinavian Journal of Gastroenterology, January 2021, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

121. 
     CELL-FREE DNA AND CLINICAL CHARACTERISTICS IN PATIENTS WITH SMALL INTESTINAL OR PANCREATIC NEUROENDOCRINE TUMORS

     Article • Neuroendocrinology, January 2021, Karger Publishers

     Clinical Chair Professor Henning Gronbaek

122. 
     Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis

     Article • Frontiers in Medicine, January 2021, Frontiers

     Clinical Chair Professor Henning Gronbaek

123. 
     Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data

     Article • Gastroenterology, January 2021, Elsevier

     Clinical Chair Professor Henning Gronbaek

124. 
     Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver Disease

     Article • Frontiers in Medicine, December 2020, Frontiers

     Clinical Chair Professor Henning Gronbaek

125. 
     PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3

     Article • PLOS One, December 2020, PLOS

     Clinical Chair Professor Henning Gronbaek

126. 
     Macrophage markers and innate immunity in cirrhosis

     Article • Journal of Hepatology, December 2020, Elsevier

     Clinical Chair Professor Henning Gronbaek

127. 
     Altered balance between collagen formation and degradation after successful direct‐acting antiviral therapy of chronic hepatitis C

     Article • Journal of Viral Hepatitis, November 2020, Wiley

     Clinical Chair Professor Henning Gronbaek

128. 
     First trimester biomarkers for prediction of gestational diabetes mellitus

     Article • Placenta, November 2020, Elsevier

     Clinical Chair Professor Henning Gronbaek

129. 
     Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS

     Article • Journal of Hepatology, November 2020, Elsevier

     Clinical Chair Professor Henning Gronbaek

130. 
     TERT promoter mutated circulating tumor DNA as a biomarker for prognosis in hepatocellular carcinoma

     Article • Scandinavian Journal of Gastroenterology, October 2020, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

131. 
     Combining Tissue and Circulating Tumor DNA Increases the Detection Rate of CTNNB1 Mutation in Hepatocellular Carcinoma

     Article • October 2020, Research Square

     Clinical Chair Professor Henning Gronbaek

132. 
     Thrombophilia testing in patients with portal vein thrombosis

     Article • Scandinavian Journal of Clinical and Laboratory Investigation, October 2020, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

133. 
     One Year’s Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial

     Article • Journal of Clinical Medicine, October 2020, MDPI AG

     Clinical Chair Professor Henning Gronbaek

134. 
     A consensus developed morphological re-evaluation of 196 high-grade gastroenteropancreatic neuroendocrine neoplasms and its clinical correlations.

     Article • Neuroendocrinology, October 2020, Karger Publishers

     Clinical Chair Professor Henning Gronbaek

135. 
     The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

     Article • Journal of Hepatology, October 2020, Elsevier

     Clinical Chair Professor Henning Gronbaek, Dr Maurizio Baldassarre, Dr Vishal C Patel

136. 
     Current perspectives on the pathophysiology of metabolic associated fatty liver disease: are macrophages a viable target for therapy?

     Article • Expert Review of Gastroenterology & Hepatology, September 2020, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

137. 
     Serological Biomarkers of Tissue Turnover Identify Responders to Anti-TNF Therapy in Crohn's Disease: A Pilot Study

     Article • Clinical and Translational Gastroenterology, September 2020, Wolters Kluwer Health

     Clinical Chair Professor Henning Gronbaek

138. 
     The effect of acute intragastric vs. intravenous alcohol administration on inflammation markers, blood lipids and gallbladder motility in healthy men

     Article • Alcohol, September 2020, Elsevier

     Clinical Chair Professor Henning Gronbaek

139. 
     1006P PD-L1, tumor mutational burden, and overall survival among patients undergoing surgical treatment for hepatocellular carcinoma prior to systemic therapy

     Article • Annals of Oncology, September 2020, Elsevier

     Clinical Chair Professor Henning Gronbaek

140. 
     Letter: improve survival! Place early pre-emptive TIPSS in high-risk variceal bleeders

     Article • Alimentary Pharmacology & Therapeutics, August 2020, Wiley

     Clinical Chair Professor Henning Gronbaek

141. 
     Early normalization of reduced urea synthesis capacity after direct-acting antiviral therapy in hepatitis C cirrhosis

     Article • AJP Gastrointestinal and Liver Physiology, August 2020, American Physiological Society

     Clinical Chair Professor Henning Gronbaek

142. 
     Progression of non-alcoholic fatty liver disease is rare in a Danish tertiary liver centre

     Article • Journal of Hepatology, August 2020, Elsevier

     Clinical Chair Professor Henning Gronbaek

143. 
     Early-tips should be performed in high-risk cirrhotic patients despite the presence of hepatic encephalopathy at admission

     Article • Journal of Hepatology, August 2020, Elsevier

     Clinical Chair Professor Henning Gronbaek

144. 
     Pre-emptive (early) transjugular intrahepatic porto-systemic shunt in the treatment of high-risk acute variceal bleeding. An individual patient data meta-analysis

     Article • Journal of Hepatology, August 2020, Elsevier

     Clinical Chair Professor Henning Gronbaek

145. 
     A plasma protein biomarker strategy for detection of small intestinal neuroendocrine tumors

     Article • Neuroendocrinology, July 2020, Karger Publishers

     Clinical Chair Professor Henning Gronbaek

146. 
     Clinical Efficacy of First and Second Series of Peptide Receptor Radionuclide Therapy in Patients With Neuroendocrine Neoplasm: A Cohort Study

     Article • July 2020, Research Square

     Clinical Chair Professor Henning Gronbaek

147. 
     Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis

     Article • BMC Gastroenterology, July 2020, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

148. 
     The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson’s disease

     Article • Orphanet Journal of Rare Diseases, July 2020, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

149. 
     A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

     Article • Journal of Hepatology, July 2020, Elsevier

     Clinical Chair Professor Henning Gronbaek

150. 
     Liver-related effects of chronic hepatitis C antiviral treatment

     Article • World Journal of Gastroenterology, June 2020, Baishideng Publishing Group Co., Limited (formerly WJG Press)

     Clinical Chair Professor Henning Gronbaek

151. 
     Fibrogenesis and inflammation contribute to the pathogenesis of cirrhotic cardiomyopathy

     Article • Alimentary Pharmacology & Therapeutics, June 2020, Wiley

     Clinical Chair Professor Henning Gronbaek

152. 
     Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute‐on‐chronic liver failure and acute decompensation

     Article • Journal of Gastroenterology and Hepatology, June 2020, Wiley

     Clinical Chair Professor Henning Gronbaek

153. 
     Correction to ‘Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF’ [J Hepatol 2020 (72) 688–701]

     Article • Journal of Hepatology, June 2020, Elsevier

     Clinical Chair Professor Henning Gronbaek, Dr Maurizio Baldassarre

154. 
     The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver Disease

     Article • Trends in Genetics, June 2020, Elsevier

     Clinical Chair Professor Henning Gronbaek

155. 
     Contrast-enhanced ultrasound compared with computed tomography, magnetic resonance imaging, and positron emission tomography-computed tomography for diagnosing liver metastases in people with newly diagnosed colorectal cancer

     Article • Cochrane Database of Systematic Reviews, May 2020, Wiley

     Clinical Chair Professor Henning Gronbaek

156. 
     Extracellular vesicle-associated soluble CD163 and CD206 in patients with acute and chronic inflammatory liver disease

     Article • Scandinavian Journal of Gastroenterology, May 2020, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

157. 
     Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure

     Article • Cells, May 2020, MDPI AG

     Clinical Chair Professor Henning Gronbaek

158. 
     Soluble PD1 levels are increased with disease activity in paediatric onset autoimmune hepatitis and inflammatory bowel disease

     Article • Autoimmunity, May 2020, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

159. 
     MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease

     Article • Gastroenterology, May 2020, Elsevier

     Clinical Chair Professor Henning Gronbaek

160. 
     Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis

     Article • Liver International, April 2020, Wiley

     Clinical Chair Professor Henning Gronbaek

161. 
     The Citrullinated and MMP-degraded Vimentin Biomarker (VICM) Predicts Early Response to Anti-TNFα Treatment in Crohn’s Disease

     Article • Journal of Clinical Gastroenterology, April 2020, Wolters Kluwer Health

     Clinical Chair Professor Henning Gronbaek

162. 
     Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF

     Article • Journal of Hepatology, April 2020, Elsevier

     Clinical Chair Professor Henning Gronbaek, Dr Maurizio Baldassarre

163. 
     Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors

     Article • Anti-Cancer Drugs, March 2020, Wolters Kluwer Health

     Clinical Chair Professor Henning Gronbaek

164. 
     New tight junction protein 2 variant causing progressive familial intrahepatic cholestasis type 4 in adults: A case report

     Article • World Journal of Gastroenterology, February 2020, Baishideng Publishing Group Co., Limited (formerly WJG Press)

     Clinical Chair Professor Henning Gronbaek

165. 
     Atorvastatin for prevention of disease progression and hospitalisation in liver cirrhosis: protocol for a randomised, double-blind, placebo-controlled trial

     Article • BMJ Open, January 2020, BMJ

     Dr Nina Kimer, Clinical Chair Professor Henning Gronbaek

166. 
     Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

     Article • The Lancet, December 2019, Elsevier

     Clinical Chair Professor Henning Gronbaek

167. 
     Plasma chromogranin A (CgA) as a predictor of progression in patients with neuroendocrine tumors.

     Article • Neuroendocrinology, October 2019, Karger Publishers

     Clinical Chair Professor Henning Gronbaek

168. 
     Time‐dependent improvement of liver inflammation, fibrosis and metabolic liver function after successful direct‐acting antiviral therapy of chronic hepatitis C

     Article • Journal of Viral Hepatitis, October 2019, Wiley

     Clinical Chair Professor Henning Gronbaek

169. 
     Use of complimentary medicines in patients with neuroendocrine tumors.

     Article • Scandinavian Journal of Gastroenterology, August 2019, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

170. 
     Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis

     Article • Clinical Gastroenterology and Hepatology, August 2019, Elsevier

     Clinical Chair Professor Henning Gronbaek

171. 
     Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2 trial

     Article • EBioMedicine, August 2019, Elsevier

     Clinical Chair Professor Henning Gronbaek

172. 
     Insulin resistance, liver inflammation and fibrosis in patients with NAFLD

     Article • Journal of Hepatology, July 2019, Elsevier

     Clinical Chair Professor Henning Gronbaek, Dr Amalia Gastaldelli

173. 
     The macrophage‐related biomarkers sCD163 and sCD206 are released by different shedding mechanisms

     Article • Journal of Leukocyte Biology, June 2019, Wiley

     Clinical Chair Professor Henning Gronbaek

174. 
     551 OPTIMAL TIMING OF ENDOSCOPY IS ASSOCIATED WITH LOWER 42-DAY MORTALITY IN VARICEAL BLEEDING

     Article • Gastrointestinal Endoscopy, June 2019, Elsevier

     Clinical Chair Professor Henning Gronbaek

175. 
     Non-alcoholic steatohepatitis, but not simple steatosis, disturbs the functional homogeneity of the liver - a human galactose positron emission tomography study

     Article • Alimentary Pharmacology & Therapeutics, May 2019, Wiley

     Clinical Chair Professor Henning Gronbaek

176. 
     Macrophage markers soluble CD163 and soluble mannose receptor are associated with liver injury in patients with paracetamol overdose

     Article • Scandinavian Journal of Gastroenterology, May 2019, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

177. 
     The Macrophage Activation Marker Soluble CD163 is Associated With Early Allograft Dysfunction After Liver Transplantation

     Article • Journal of Clinical and Experimental Hepatology, May 2019, Elsevier

     Clinical Chair Professor Henning Gronbaek

178. 
     Hepatic exposure of metformin in patients with non‐alcoholic fatty liver disease

     Article • British Journal of Clinical Pharmacology, April 2019, Wiley

     Clinical Chair Professor Henning Gronbaek

179. 
     Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals

     Article • AJP Gastrointestinal and Liver Physiology, April 2019, American Physiological Society

     Clinical Chair Professor Henning Gronbaek

180. 
     FRI-339-Clinical translatability of a diet-induced obese mouse model of non-alcoholic steatohepatitis

     Article • Journal of Hepatology, April 2019, Elsevier

     Clinical Chair Professor Henning Gronbaek

181. 
     PS-023-Factors predicting survival in patients with high-risk acute variceal bleeding treated with pre-emptive (Early)-TIPS

     Article • Journal of Hepatology, April 2019, Elsevier

     Clinical Chair Professor Henning Gronbaek

182. 
     THU-324-Non-alcoholic fatty liver disease causes dissociated changes in metabolic liver functions

     Article • Journal of Hepatology, April 2019, Elsevier

     Clinical Chair Professor Henning Gronbaek

183. 
     PS-022-Optimal timing of endoscopy is associated with lower 42-day mortality in variceal bleeding

     Article • Journal of Hepatology, April 2019, Elsevier

     Clinical Chair Professor Henning Gronbaek

184. 
     THU-325-Regional liver function investigated by galactose positron emission tomography is reduced in patients with non-alcoholic steatohepatitis

     Article • Journal of Hepatology, April 2019, Elsevier

     Clinical Chair Professor Henning Gronbaek

185. 
     SAT-079-Respiratory infection in patients with cirrhosis and acute variceal bleeding on antibiotic prophylaxis: A multicenter observational study of 2138 patients

     Article • Journal of Hepatology, April 2019, Elsevier

     Clinical Chair Professor Henning Gronbaek

186. 
     FRI-120-Structural liver disease rather than portal hypertension is the predominant factor for hepatic macrophage activation in patients with cirrhosis, portal vein thrombosis and idiopathic portal hypertension

     Article • Journal of Hepatology, April 2019, Elsevier

     Clinical Chair Professor Henning Gronbaek

187. 
     FRI-016-Validation of the PREsTo machine learning algorithm for the prediction of disease progression in patients with primary sclerosing cholangitis

     Article • Journal of Hepatology, April 2019, Elsevier

     Clinical Chair Professor Henning Gronbaek

188. 
     Effects of implementation of a national fast track clinical pathway for hepatocellular carcinoma in western Denmark

     Article • Journal of Gastrointestinal and Liver Diseases, March 2019, Romanian Society of Gastroenterology and Heptatology

     Clinical Chair Professor Henning Gronbaek

189. 
     Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects

     Article • World Journal of Hepatology, February 2019, Baishideng Publishing Group Co., Limited (formerly WJG Press)

     Clinical Chair Professor Henning Gronbaek

190. 
     Non-alcoholic fatty liver disease causes dissociated changes in metabolic liver functions

     Article • Clinics and Research in Hepatology and Gastroenterology, February 2019, Elsevier

     Clinical Chair Professor Henning Gronbaek

191. 
     The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark

     Article • Growth Hormone & IGF Research, February 2019, Elsevier

     Clinical Chair Professor Henning Gronbaek

192. 
     P282 Combination of biomarkers reflecting type IV collagen degradation and citrullinated vimentin predicts response to adalimumab with high diagnostic accuracy, in patients with Crohn’s disease

     Article • Journal of Crohn s and Colitis, January 2019, Oxford University Press (OUP)

     Clinical Chair Professor Henning Gronbaek

193. 
     Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors

     Article • BMC Cancer, January 2019, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

194. 
     Preemptive‐TIPS Improves Outcome in High‐Risk Variceal Bleeding: An Observational Study

     Article • Hepatology, December 2018, Wiley

     Dr Joan Genesca, Clinical Chair Professor Henning Gronbaek

195. 
     Orchestration of Tryptophan-Kynurenine pathway, acute decompensation and acute-on-chronic liver failure in cirrhosis

     Article • Hepatology, December 2018, Wiley

     Clinical Chair Professor Henning Gronbaek

196. 
     The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

     Article • Nature Reviews Gastroenterology & Hepatology, November 2018, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

197. 
     Macrophage Markers Are Poorly Associated With Liver Histology in Children With Nonalcoholic Fatty Liver Disease

     Article • Journal of Pediatric Gastroenterology and Nutrition, November 2018, Wolters Kluwer Health

     Clinical Chair Professor Henning Gronbaek

198. 
     Urea cycle dysregulation in non-alcoholic fatty liver disease

     Article • Journal of Hepatology, October 2018, Elsevier

     Clinical Chair Professor Henning Gronbaek

199. 
     High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study

     Article • Orphanet Journal of Rare Diseases, September 2018, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

200. 
     No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial

     Article • PLOS One, September 2018, PLOS

     Clinical Chair Professor Henning Gronbaek

201. 
     The Risk of Second Primary Colorectal Adenocarcinomas is not Increased among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms – A Nationwide Population Based Study

     Article • Neuroendocrinology, August 2018, Karger Publishers

     Clinical Chair Professor Henning Gronbaek, Tine Gregersen

202. 
     The role of IFN in the development of NAFLD and NASH

     Article • Cytokine, August 2018, Elsevier

     Clinical Chair Professor Henning Gronbaek

203. 
     β-Blockers Improve Presinusoidal Portal Hypertension

     Article • Digestive Diseases and Sciences, July 2018, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

204. 
     Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology

     Article • Scandinavian Journal of Gastroenterology, July 2018, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

205. 
     No effect of resveratrol on VLDL-TG kinetics and insulin sensitivity in obese men with nonalcoholic fatty liver disease

     Article • Diabetes Obesity and Metabolism, July 2018, Wiley

     Clinical Chair Professor Henning Gronbaek

206. 
     The Effect of Ethanol on Inflammation Markers and FGF-21 in Healthy Individuals

     Article • Diabetes, July 2018, American Diabetes Association

     Clinical Chair Professor Henning Gronbaek

207. 
     Soluble CD163 correlates with lipid metabolic adaptations in human type 1 diabetes patients during ketoacidosis

     Article • Journal of Diabetes Investigation, May 2018, Wiley

     Clinical Chair Professor Henning Gronbaek

208. 
     Effects of direct-acting antiviral treatment of chronic hepatitis C on macrophage activation, liver stiffness, metabolic liver function and portal hypertension in cirrhosis patients

     Article • Journal of Hepatology, April 2018, Elsevier

     Clinical Chair Professor Henning Gronbaek

209. 
     Albumin administration in the prevention of hepatorenal syndrome (HRS) and death in patients with advanced cirrhosis and non-SBP infections

     Article • Journal of Hepatology, April 2018, Elsevier

     Clinical Chair Professor Henning Gronbaek

210. 
     Combinations of inflammatory markers, soluble (s)CD163, mannose receptor (sMR) and neutrophil gelatinase associated lipocalin (NGAL), predicts mortality in patients with acute-on-chronic liver failure

     Article • Journal of Hepatology, April 2018, Elsevier

     Clinical Chair Professor Henning Gronbaek

211. 
     Epigenetic modification of urea cycle enzymes in NAFLD animal models and patients: Implications for novel therapeutic approaches

     Article • Journal of Hepatology, April 2018, Elsevier

     Clinical Chair Professor Henning Gronbaek

212. 
     Loss of colonization resistance in cirrhosis facilitates proton pump inhibitor-associated oralization of the colonic microbiome

     Article • Journal of Hepatology, April 2018, Elsevier

     Clinical Chair Professor Henning Gronbaek

213. 
     Prognosis in patients with primary biliary cholangitis based on histological stage at diagnosis. A nationwide population-based study

     Article • Journal of Hepatology, April 2018, Elsevier

     Clinical Chair Professor Henning Gronbaek

214. 
     The Galactose Elimination Capacity test may monitor treatment response and disease progression in patients with Wilson Disease

     Article • Journal of Hepatology, April 2018, Elsevier

     Clinical Chair Professor Henning Gronbaek

215. 
     The kynurenine pathway in cirrhosis. Relationship with the development of acute decompensation and acute-on-chronic liver failure, clinical course and mortality

     Article • Journal of Hepatology, April 2018, Elsevier

     Clinical Chair Professor Henning Gronbaek

216. 
     Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease

     Article • PLOS One, March 2018, PLOS

     Clinical Chair Professor Henning Gronbaek

217. 
     Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)

     Article • Medical Oncology, March 2018, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

218. 
     Adult Presentation of Noncirrhotic Portal Hypertension and Ascites following Treatment for Wilms’ Tumor in Childhood

     Article • Case Reports in Gastroenterology, February 2018, Karger Publishers

     Linda Kievit, Clinical Chair Professor Henning Gronbaek

219. 
     Preserved liver regeneration capacity after partial hepatectomy in rats with non-alcoholic steatohepatitis

     Article • World Journal of Hepatology, January 2018, Baishideng Publishing Group Co., Limited (formerly WJG Press)

     Clinical Chair Professor Henning Gronbaek

220. 
     Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment

     Article • Journal of Gastroenterology and Hepatology, January 2018, Wiley

     Clinical Chair Professor Henning Gronbaek, Prof Henry LY Chan

221. 
     Nutritional status and nutritional risk in patients with neuroendocrine tumors

     Article • Scandinavian Journal of Gastroenterology, January 2018, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

222. 
     Cell death markers in patients with cirrhosis and acute decompensation

     Article • Hepatology, January 2018, Wiley

     Clinical Chair Professor Henning Gronbaek

223. 
     Unexplained cholestasis in adults and adolescents: diagnostic benefit of genetic examination

     Article • Scandinavian Journal of Gastroenterology, January 2018, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

224. 
     Macrophage activation marker sCD163 correlates with accelerated lipolysis following LPS exposure: a human-randomised clinical trial

     Article • Endocrine Connections, January 2018, Bioscientifica

     Clinical Chair Professor Henning Gronbaek

225. 
     Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation

     Article • Alimentary Pharmacology & Therapeutics, December 2017, Wiley

     Clinical Chair Professor Henning Gronbaek

226. 
     The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients

     Article • PLOS One, December 2017, PLOS

     Clinical Chair Professor Henning Gronbaek

227. 
     Corrigendum

     Article • Alimentary Pharmacology & Therapeutics, December 2017, Wiley

     Clinical Chair Professor Henning Gronbaek

228. 
     Effects of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Goblet Cell Carcinoma: A Prospective Cohort Study

     Article • Annals of Surgical Oncology, December 2017, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

229. 
     Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial

     Article • The Lancet Oncology, December 2017, Elsevier

     Clinical Chair Professor Henning Gronbaek

230. 
     Time course of compromised urea synthesis in patients with alcoholic hepatitis

     Article • Scandinavian Journal of Gastroenterology, November 2017, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

231. 
     Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma

     Article • PLOS One, November 2017, PLOS

     Clinical Chair Professor Henning Gronbaek

232. 
     Wet Biomarker-Based Assessment of Steatosis, Inflammation, and Fibrosis in NAFLD

     Article • Current Hepatology Reports, October 2017, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

233. 
     Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas

     Article • European Journal of Surgical Oncology, September 2017, Elsevier

     Clinical Chair Professor Henning Gronbaek

234. 
     High burden of coronary atherosclerosis in patients with cirrhosis

     Article • European Journal of Clinical Investigation, July 2017, Wiley

     Clinical Chair Professor Henning Gronbaek

235. 
     Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease

     Article • Scandinavian Journal of Clinical and Laboratory Investigation, July 2017, Taylor & Francis

     Dr Mark W Douglas, Clinical Chair Professor Henning Gronbaek, professor adrian bauman

236. 
     Letter: autoimmune hepatitis-drug-induced liver injury must always be excluded. Authors’ reply

     Article • Alimentary Pharmacology & Therapeutics, July 2017, Wiley

     Clinical Chair Professor Henning Gronbaek

237. 
     A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors

     Article • Endocrine Related Cancer, June 2017, Bioscientifica

     Clinical Chair Professor Henning Gronbaek

238. 
     Isolated congenital hepatic fibrosis associated with TMEM67 mutations: report of a new genotype-phenotype relationship

     Article • Clinical Case Reports, May 2017, Wiley

     Clinical Chair Professor Henning Gronbaek

239. 
     Enrichment of Genetic Variants in the Glucocorticoid Receptor Signalling Pathway in Autoimmune Hepatitis with Failure of Standard Treatment

     Article • Basic & Clinical Pharmacology & Toxicology, May 2017, Wiley

     Clinical Chair Professor Henning Gronbaek

240. 
     Survival and Predictors of Death for Patients with Bronchopulmonary Carcinoid at a Danish Tertiary NET Centre

     Article • In Vivo, April 2017, International Institute of Anticancer Research

     Clinical Chair Professor Henning Gronbaek

241. 
     Men with biopsy-confirmed hepatocellular adenoma have a high risk of progression to hepatocellular carcinoma: A nationwide population-based study

     Article • Liver International, April 2017, Wiley

     Clinical Chair Professor Henning Gronbaek

242. 
     IFN-λ3, not IFN-λ4, likely mediates IFNL3–IFNL4 haplotype–dependent hepatic inflammation and fibrosis

     Article • Nature Genetics, April 2017, Nature

     Clinical Chair Professor Henning Gronbaek

243. 
     Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes

     Article • Molecular Therapy — Methods & Clinical Development, March 2017, Elsevier

     Clinical Chair Professor Henning Gronbaek

244. 
     Long-Term Ethanol Exposure Decreases the Endotoxin-Induced Hepatic Acute Phase Response in Rats

     Article • Alcoholism Clinical and Experimental Research, February 2017, Wiley

     Emilie Glavind, Clinical Chair Professor Henning Gronbaek

245. 
     Time Course of Compromised Urea Synthesis in Patients With Alcoholic Hepatitis

     Article • Journal of Clinical and Experimental Hepatology, February 2017, Elsevier

     Clinical Chair Professor Henning Gronbaek

246. 
     Soluble CD163 (sCD163): Biomarker of Kupffer Cell Activation in Liver Disease

     Article • January 2017, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

247. 
     Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting

     Article • Acta Dermato-Venereologica, January 2017, Acta Dermato-Venereologica

     Clinical Chair Professor Henning Gronbaek

248. 
     Enrichment of genetic variants in the glucocorticoid receptor signalling pathway in standard treatment failure autoimmune hepatitis

     Article • Journal of Hepatology, January 2017, Elsevier

     Clinical Chair Professor Henning Gronbaek

249. 
     Macrophage activation markers sCD163 and mannose receptor predict survival and correlate with markers of gut permeability in patients with liver cirrhosis

     Article • Journal of Hepatology, January 2017, Elsevier

     Clinical Chair Professor Henning Gronbaek

250. 
     Soluble (s)CD163 a macrophage activation marker is associated with liver disease severity in patients with Wilson’s disease

     Article • Journal of Hepatology, January 2017, Elsevier

     Clinical Chair Professor Henning Gronbaek

251. 
     The macrophage activation marker, soluble CD163 is associated with hepatic inflammation and fibrosis in chronic viral hepatitis C and declines during effective direct-acting antiviral therapy

     Article • Journal of Hepatology, January 2017, Elsevier

     Clinical Chair Professor Henning Gronbaek

252. 
     The novel macrophage activation marker soluble Mannose Receptor, and soluble CD163, are elevated after acetaminophen intoxication in relation to liver disease severity

     Article • Journal of Hepatology, January 2017, Elsevier

     Clinical Chair Professor Henning Gronbaek

253. 
     Time course of compromised urea synthesis in patients with alcoholic hepatitis

     Article • Journal of Hepatology, January 2017, Elsevier

     Clinical Chair Professor Henning Gronbaek

254. 
     Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls

     Article • International Journal of Obesity, December 2016, Nature

     Clinical Chair Professor Henning Gronbaek, Steen B. Pedersen

255. 
     A descriptive cross-sectional study of pain in patients with neuroendocrine tumors

     Article • Scandinavian Journal of Gastroenterology, November 2016, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

256. 
     Polymorphisms in the IL‐1 gene cluster influence systemic inflammation in patients at risk for acute‐on‐chronic liver failure

     Article • Hepatology, November 2016, Wiley

     Professor Mauro Bernardi, Clinical Chair Professor Henning Gronbaek

257. 
     Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis

     Article • Liver International, November 2016, Wiley

     Dr Joan Genesca, Clinical Chair Professor Henning Gronbaek

258. 
     The soluble mannose receptor is released from the liver in cirrhotic patients, but is not associated with bacterial translocation

     Article • Liver International, October 2016, Wiley

     Clinical Chair Professor Henning Gronbaek

259. 
     Contrast-enhanced ultrasound compared with computed tomography, magnetic resonance imaging, and positron emission tomography for diagnosing liver metastases in people with newly diagnosed colorectal cancer

     Article • Cochrane Database of Systematic Reviews, October 2016, Wiley

     Clinical Chair Professor Henning Gronbaek

260. 
     Fibrosis is not just fibrosis - basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injury

     Article • Alimentary Pharmacology & Therapeutics, October 2016, Wiley

     Clinical Chair Professor Henning Gronbaek

261. 
     Role of macrophages and macrophage activation marker sCD163 in patients with autoimmune hepatitis

     Article • Alimentary Pharmacology & Therapeutics, September 2016, Wiley

     Clinical Chair Professor Henning Gronbaek

262. 
     Soluble programmed death-1 levels are associated with disease activity and treatment response in patients with autoimmune hepatitis

     Article • Scandinavian Journal of Gastroenterology, September 2016, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

263. 
     MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C

     Article • Nature Communications, September 2016, Nature

     Clinical Chair Professor Henning Gronbaek

264. 
     Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure

     Article • Hepatology, August 2016, Wiley

     Clinical Chair Professor Henning Gronbaek

265. 
     Alcoholic Hepatitis Markedly Decreases the Capacity for Urea Synthesis

     Article • PLOS One, July 2016, PLOS

     Clinical Chair Professor Henning Gronbaek

266. 
     The damage-associated molecular pattern HMGB1 is elevated in human alcoholic hepatitis, but does not seem to be a primary driver of inflammation

     Article • Apmis, June 2016, Wiley

     Clinical Chair Professor Henning Gronbaek

267. 
     Editorial: measuring inflammatory and fibrotic components of portal hypertension - a non-invasive hepatic venous pressure gradient? Authors’ reply

     Article • Alimentary Pharmacology & Therapeutics, June 2016, Wiley

     Clinical Chair Professor Henning Gronbaek

268. 
     Reduced sCD36 following weight loss corresponds to improved insulin sensitivity, dyslipidemia and liver fat in obese children

     Article • European Journal of Clinical Nutrition, June 2016, Nature

     Clinical Chair Professor Henning Gronbaek

269. 
     The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease

     Article • Liver International, May 2016, Wiley

     Clinical Chair Professor Henning Gronbaek

270. 
     Rectal Mechano-sensory Function in Patients with Carcinoid Diarrhea

     Article • Journal of Neurogastroenterology and Motility, April 2016, The Korean Society of Neurogastroenterology and Motility

     Clinical Chair Professor Henning Gronbaek, Tine Gregersen

271. 
     The macrophage activation marker sCD163 combined with markers of the Enhanced Liver Fibrosis (ELF) score predicts clinically significant portal hypertension in patients with cirrhosis

     Article • Alimentary Pharmacology & Therapeutics, April 2016, Wiley

     Clinical Chair Professor Henning Gronbaek

272. 
     Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF)

     Article • Journal of Hepatology, April 2016, Elsevier

     Clinical Chair Professor Henning Gronbaek

273. 
     Impaired Insulin Suppression of VLDL-Triglyceride Kinetics in Nonalcoholic Fatty Liver Disease

     Article • The Journal of Clinical Endocrinology & Metabolism, April 2016, Endocrine Society

     Clinical Chair Professor Henning Gronbaek, Steen B. Pedersen

274. 
     Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure

     Article • Journal of Hepatology, March 2016, Elsevier

     Clinical Chair Professor Henning Gronbaek

275. 
     Effect of resveratrol on experimental non-alcoholic fatty liver disease depends on severity of pathology and timing of treatment

     Article • Journal of Gastroenterology and Hepatology, February 2016, Wiley

     Clinical Chair Professor Henning Gronbaek, Steen B. Pedersen

276. 
     Adipose tissue insulin resistance is associated with macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease

     Article • Digestive and Liver Disease, February 2016, Elsevier

     Clinical Chair Professor Henning Gronbaek, Dr Amalia Gastaldelli

277. 
     Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease

     Article • Scandinavian Journal of Gastroenterology, January 2016, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek, Steen B. Pedersen

278. 
     Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study

     Article • January 2016, Bioscientifica

     Clinical Chair Professor Henning Gronbaek

279. 
     Anti-CD163-dexamethasone conjugate inhibits the acute phase response to lipopolysaccharide in rats

     Article • World Journal of Hepatology, January 2016, Baishideng Publishing Group Co., Limited (formerly WJG Press)

     Clinical Chair Professor Henning Gronbaek

280. 
     Soluble CD163 (sCD163): Biomarker of Kupffer Cell Activation in Liver Disease

     Article • January 2016, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

281. 
     Adipose Tissue Insulin Resistance is Associated with Macrophage Activation in Non-Diabetic Patients with Non-Alcoholic Fatty Liver Disease

     Article • Journal of Hepatology, January 2016, Elsevier

     Clinical Chair Professor Henning Gronbaek, Dr Amalia Gastaldelli

282. 
     Circulating CD36 Correlates with Intrahepatic Lipid Content in Non-Alcoholic Fatty Liver Disease Patients

     Article • Journal of Hepatology, January 2016, Elsevier

     Clinical Chair Professor Henning Gronbaek

283. 
     Disease-Related Variants in Genes Involved in Bile Formation and Transport Demonstrated in 12 of 22 Patients with “Unexplained Cholestasis” by the Use of a Novel Panel for Genetic Testing

     Article • Journal of Hepatology, January 2016, Elsevier

     Clinical Chair Professor Henning Gronbaek

284. 
     Liver Regeneration Capacity after Partial Hepatectomy in Rats with Non-Alcoholic Steatohepatitis

     Article • Journal of Hepatology, January 2016, Elsevier

     Clinical Chair Professor Henning Gronbaek

285. 
     Macrophage Activation Assessed by Soluble CD163 and Soluble Mannose Receptor is Associated with Liver Injury in Patients with Acetaminophen Overdose

     Article • Journal of Hepatology, January 2016, Elsevier

     Clinical Chair Professor Henning Gronbaek

286. 
     Patients with Liver Cirrhosis Have Similar Prevalence, but Higher Burden of Coronary Artery Disease Compared to Patients Evaluated for Angina Pectoris

     Article • Journal of Hepatology, January 2016, Elsevier

     Clinical Chair Professor Henning Gronbaek

287. 
     Polymorphismus in the Interleukin (IL)-1 Gene Cluster Influence the Inflammatory Burden in Patients with Decompensated Cirrhosis and Acute-On-Chronic Liver Failure

     Article • Journal of Hepatology, January 2016, Elsevier

     Clinical Chair Professor Henning Gronbaek

288. 
     Soluble CD163, a Marker of Macrophage Activation, is Increased in Early Allograft Dysfunction after Liver Transplantation

     Article • Journal of Hepatology, January 2016, Elsevier

     Clinical Chair Professor Henning Gronbaek

289. 
     Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative Study

     Article • Annals of Surgical Oncology, December 2015, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

290. 
     Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma

     Article • Scandinavian Journal of Clinical and Laboratory Investigation, November 2015, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

291. 
     Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients

     Article • PLOS One, September 2015, PLOS

     Clinical Chair Professor Henning Gronbaek

292. 
     Combination of radiofrequency ablation with transarterial chemoembolization for treatment of hepatocellular carcinoma: experience from a Danish tertiary liver center

     Article • Acta Radiologica, September 2015, SAGE Publications

     Clinical Chair Professor Henning Gronbaek

293. 
     The Circulating IGF System in Hepatocellular Carcinoma: The Impact of Liver Status and Treatment

     Article • Growth Hormone & IGF Research, August 2015, Elsevier

     Clinical Chair Professor Henning Gronbaek

294. 
     Diagnosis and treatment of bronchopulmonary neuroendocrine tumours: State of the art

     Article • Acta Oncologica, July 2015, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

295. 
     Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery

     Article • Journal of Gastroenterology and Hepatology, July 2015, Wiley

     Clinical Chair Professor Henning Gronbaek

296. 
     Regional Gastrointestinal Transit Times in Patients With Carcinoid Diarrhea: Assessment With the Novel 3D-Transit System

     Article • Journal of Neurogastroenterology and Motility, July 2015, The Korean Society of Neurogastroenterology and Motility

     Clinical Chair Professor Henning Gronbaek, Tine Gregersen

297. 
     Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis

     Article • Hepatology, May 2015, Wiley

     Clinical Chair Professor Henning Gronbaek

298. 
     Monitoring Kidney Function in Neuroendocrine Tumor Patients Treated with 90Y-DOTATOC: Associations with Risk Factors

     Article • Current Radiopharmaceuticals, May 2015, Bentham Science Publishers

     Clinical Chair Professor Henning Gronbaek

299. 
     Effect of resveratrol on experimental non-alcoholic steatohepatitis

     Article • Pharmacological Research, May 2015, Elsevier

     Clinical Chair Professor Henning Gronbaek, Steen B. Pedersen

300. 
     The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure

     Article • Journal of Hepatology, April 2015, Elsevier

     Clinical Chair Professor Henning Gronbaek

301. 
     Macrophage activation in obese children with non-alcoholic fatty liver diease

     Article • Journal of Hepatology, April 2015, Elsevier

     Clinical Chair Professor Henning Gronbaek

302. 
     P0974 : Effects of resveratrol on experimental non-alcoholic steatohepatitis

     Article • Journal of Hepatology, April 2015, Elsevier

     Clinical Chair Professor Henning Gronbaek

303. 
     P1044 : Randomised, placebo-controlled clinical trial: Long-term resveratrol treatment for non-alcoholic fatty liver disease

     Article • Journal of Hepatology, April 2015, Elsevier

     Clinical Chair Professor Henning Gronbaek

304. 
     P1061 : The macrophage activation marker SCD163 and the apoptosis marker cytokeratin-18 are both predictors of disease severity in patients with non-alcoholic fatty liver disease

     Article • Journal of Hepatology, April 2015, Elsevier

     Clinical Chair Professor Henning Gronbaek

305. 
     LP21 : The macrophage activation markers soluble CD206 And CD163 predict mortality in patients with liver cirrhosis and acute-on-chronic liver failure (ACLF)

     Article • Journal of Hepatology, April 2015, Elsevier

     Clinical Chair Professor Henning Gronbaek

306. 
     Goblet Cell Carcinoids: Characteristics of a Danish Cohort of 83 Patients

     Article • PLOS One, February 2015, PLOS

     Professor Andreas Kjaer, Clinical Chair Professor Henning Gronbaek

307. 
     Urinary aquaporin-2 excretion before and after transjugular intrahepatic portosystemic shunt insertion for refractory ascites

     Article • Scandinavian Journal of Gastroenterology, January 2015, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

308. 
     Reply

     Article • Hepatology, January 2015, Wiley

     Clinical Chair Professor Henning Gronbaek

309. 
     A Comparison of Three Chromogranin A Assays in Patients with Neuroendocrine Tumours

     Article • Journal of Gastrointestinal and Liver Diseases, December 2014, Romanian Society of Gastroenterology and Heptatology

     Clinical Chair Professor Henning Gronbaek

310. 
     Soluble CD163, a Specific Macrophage Activation Marker, is Decreased by Anti-TNF-αAntibody Treatment in Active Inflammatory Bowel Disease

     Article • Scandinavian Journal of Immunology, November 2014, Wiley

     Clinical Chair Professor Henning Gronbaek

311. 
     Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure

     Article • Journal of Hepatology, November 2014, Elsevier

     Clinical Chair Professor Henning Gronbaek

312. 
     Circulating mannan-binding lectin, M-, L-, H-ficolin and collectin-liver-1 levels in patients with acute liver failure

     Article • Liver International, September 2014, Wiley

     Clinical Chair Professor Henning Gronbaek

313. 
     Hepatic Macrophage Activation and the LPS Pathway in Patients With Alcoholic Hepatitis: A Prospective Cohort Study

     Article • The American Journal of Gastroenterology, August 2014, Nature

     Clinical Chair Professor Henning Gronbaek

314. 
     Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

     Article • Acta Oncologica, August 2014, Acta Dermato-Venereologica

     Dr Seppo W. Langer, Clinical Chair Professor Henning Gronbaek

315. 
     Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C

     Article • Hepatology, August 2014, Wolters Kluwer Health

     Clinical Chair Professor Henning Gronbaek

316. 
     The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children

     Article • Pediatric Obesity, July 2014, Wiley

     Clinical Chair Professor Henning Gronbaek

317. 
     Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors

     Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, July 2014, New England Journal of Medicine (NEJM/MMS)

     Clinical Chair Professor Henning Gronbaek

318. 
     Vitamin B12and its binding proteins in hepatocellular carcinoma and chronic liver diseases

     Article • Scandinavian Journal of Gastroenterology, June 2014, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

319. 
     Experimental nonalcoholic steatohepatitis compromises ureagenesis, an essential hepatic metabolic function

     Article • AJP Gastrointestinal and Liver Physiology, June 2014, American Physiological Society

     Clinical Chair Professor Henning Gronbaek

320. 
     Non-alcoholic steatohepatitis weakens the acute phase response to endotoxin in rats

     Article • Liver International, April 2014, Wiley

     Clinical Chair Professor Henning Gronbaek

321. 
     P320 ALCOHOLIC HEPATITIS DECREASES THE CAPACITY FOR UREA SYNTHESIS

     Article • Journal of Hepatology, April 2014, Elsevier

     Clinical Chair Professor Henning Gronbaek

322. 
     P1018 MARKERS OF COLLAGEN REMODELING DETECT CLINICALLY SIGNIFICANT FIBROSIS IN CHRONIC HEPATITIS C PATIENTS

     Article • Journal of Hepatology, April 2014, Elsevier

     Clinical Chair Professor Henning Gronbaek

323. 
     P1007 SOLUBLE CD163, A MACROPHAGE ACTIVATION MARKER, IS INDEPENDENTLY ASSOCIATED WITH FIBROSIS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS B AND C

     Article • Journal of Hepatology, April 2014, Elsevier

     Clinical Chair Professor Henning Gronbaek

324. 
     P824 SOLUBLE CD163, A MACROPHAGE ACTIVATION MARKER, IS INDEPENDENTLY ASSOCIATED WITH STEATOHEPATITIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE

     Article • Journal of Hepatology, April 2014, Elsevier

     Clinical Chair Professor Henning Gronbaek

325. 
     Effects of long-acting somatostatin analogues on redox systems in rat lens in experimental diabetes

     Article • International Journal of Experimental Pathology, March 2014, Wiley

     Clinical Chair Professor Henning Gronbaek

326. 
     Prednisolone but Not Infliximab Aggravates the Upregulated Hepatic Nitrogen Elimination in Patients with Active Inflammatory Bowel Disease

     Article • Inflammatory Bowel Diseases, January 2014, Wolters Kluwer Health

     Clinical Chair Professor Henning Gronbaek

327. 
     Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease

     Article • World Journal of Hepatology, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

     Clinical Chair Professor Henning Gronbaek, Steen B. Pedersen

328. 
     Trefoil factors in inflammatory bowel disease

     Article • World Journal of Gastroenterology, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

     Clinical Chair Professor Henning Gronbaek

329. 
     Chemoembolization of intermediate stage hepatocellular carcinomas: Results from a Nordic tertiary liver cancer center

     Article • Indian Journal of Gastroenterology, December 2013, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

330. 
     Elevated platelet expression of CD36 may contribute to increased risk of thrombo-embolism in active inflammatory bowel disease

     Article • Archives of Physiology and Biochemistry, July 2013, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

331. 
     No difference in portal and hepatic venous bacterial DNA in patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt insertion

     Article • Liver International, June 2013, Wiley

     Clinical Chair Professor Henning Gronbaek

332. 
     Propranolol treatment of portal hypertension in cirrhosis patients is better the higher the untreated pressure: a single-centre prospective experience

     Article • Scandinavian Journal of Gastroenterology, June 2013, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

333. 
     Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis

     Article • Gastroenterology, June 2013, Elsevier

     Clinical Chair Professor Henning Gronbaek

334. 
     591 BACTERIAL DNA MEASUREMENTS IN PATIENTS WITH CIRRHOSIS UNDERGOING TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) INSERTION

     Article • Journal of Hepatology, April 2013, Elsevier

     Clinical Chair Professor Henning Gronbaek

335. 
     1342 CHANGE IN SOLUBLE CD163, A MARKER OF ACTIVATED MACROPHAGES, IS ASSOCIATED WITH IMPROVEMENT IN LIVER ENZYMES AND METABOLIC PROFILE IN OBESE CHILDREN DURING LIFESTYLE INTERVENTION

     Article • Journal of Hepatology, April 2013, Elsevier

     Clinical Chair Professor Henning Gronbaek

336. 
     1301 ENDOTOXIN CAUSES HIGH MORTALITY AND REDUCED HEPATIC SYNTHESIS OF ACUTE PHASE PROTEINS IN RATS WITH EXPERIMENTAL NON-ALCOHOLIC FATTY LIVER DISEASE

     Article • Journal of Hepatology, April 2013, Elsevier

     Clinical Chair Professor Henning Gronbaek

337. 
     1414 THE CLIF-CONSORTIUM SCORE PREDICTS MORTALITY MORE ACCURATELY THAN THE MELD AND MELD-SODIUM SCORES IN PATIENTS HOSPITALIZED WITH DECOMPENSATED CIRRHOSIS WITH AND WITHOUT ACUTE-ON-CHRONIC-LIVER FAILURE (ACLF).

     Article • Journal of Hepatology, April 2013, Elsevier

     Clinical Chair Professor Henning Gronbaek

338. 
     Quantitative histological assessment of hepatic ischemia-reperfusion injuries following ischemic pre- and post-conditioning in the rat liver

     Article • Journal of Surgical Research, March 2013, Elsevier

     Clinical Chair Professor Henning Gronbaek

339. 
     Macrophage biomarkers predict prognosis in patients with liver cirrhosis

     Article • Gut, February 2013, BMJ

     Clinical Chair Professor Henning Gronbaek

340. 
     Regulation of urea synthesis during the acute-phase response in rats

     Article • AJP Gastrointestinal and Liver Physiology, February 2013, American Physiological Society

     Clinical Chair Professor Henning Gronbaek

341. 
     Highest Frequencies of Interleukin-22-Producing T Helper Cells in Alcoholic Hepatitis Patients with a Favourable Short-Term Course

     Article • PLOS One, January 2013, PLOS

     Clinical Chair Professor Henning Gronbaek

342. 
     Goblet Cell Carcinoids of the Appendix

     Article • The Scientific World JOURNAL, January 2013, Hindawi Publishing Corporation

     Clinical Chair Professor Henning Gronbaek

343. 
     Sorafenib in Advanced Hepatocellular Carcinoma: A Nationwide Retrospective Study of Efficacy and Tolerability

     Article • The Scientific World JOURNAL, January 2013, Hindawi Publishing Corporation

     Clinical Chair Professor Henning Gronbaek

344. 
     Treatment of Budd-Chiari syndrome with a focus on transjugular intrahepatic portosystemic shunt

     Article • World Journal of Hepatology, January 2013, Baishideng Publishing Group Co., Limited (formerly WJG Press)

     Clinical Chair Professor Henning Gronbaek

345. 
     Changes in adipokines after transjugular intrahepatic porto-systemic shunt indicate an anabolic shift in metabolism

     Article • Clinical Nutrition, December 2012, Elsevier

     Clinical Chair Professor Henning Gronbaek

346. 
     Small intestinal transit in patients with liver cirrhosis and portal hypertension: a descriptive study

     Article • BMC Gastroenterology, December 2012, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

347. 
     Randomized crossover study in patients with neuroendocrine tumors to assess patient preference for lanreotide Autogel® given by either self/partner or a health care professional

     Article • Patient Preference and Adherence, October 2012, Dove Medical Press

     Associate Professor Dan Granberg, PhD Jan Calissendorff, Clinical Chair Professor Henning Gronbaek

348. 
     Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study

     Article • Annals of Oncology, September 2012, Oxford University Press (OUP)

     Clinical Chair Professor Henning Gronbaek

349. 
     Insulin-like Growth Factor-I Concentration and Risk of Prostate Cancer: Results from the European Prospective Investigation into Cancer and Nutrition

     Article • Cancer Epidemiology Biomarkers & Prevention, July 2012, American Association for Cancer Research (AACR)

     Clinical Chair Professor Henning Gronbaek, Francesca Crowe

350. 
     Ischemic pre- and postconditioning has pronounced effects on gene expression profiles in the rat liver after ischemia/reperfusion

     Article • AJP Gastrointestinal and Liver Physiology, June 2012, American Physiological Society

     Clinical Chair Professor Henning Gronbaek

351. 
     Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis

     Article • Metabolic Brain Disease, May 2012, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

352. 
     Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis

     Article • Alimentary Pharmacology & Therapeutics, May 2012, Wiley

     Clinical Chair Professor Henning Gronbaek

353. 
     Effects of long-term experimental diabetes on adrenal gland growth and phosphoribosyl pyrophosphate formation in growth hormone-deficient dwarf rats

     Article • International Journal of Experimental Pathology, May 2012, Wiley

     Clinical Chair Professor Henning Gronbaek

354. 
     Cirrhosis and mortality risks of biopsy-verified alcoholic pure steatosis and steatohepatitis: a nationwide registry-based study

     Article • Alimentary Pharmacology & Therapeutics, April 2012, Wiley

     Clinical Chair Professor Henning Gronbaek

355. 
     1371 IL-22 PRODUCING T CELLS ARE ASSOCIATED WITH A FAVOURABLE DISEASE COURSE IN ALCOHOLIC HEPATITIS

     Article • Journal of Hepatology, April 2012, Elsevier

     Clinical Chair Professor Henning Gronbaek

356. 
     1375 PROGNOSIS OF ALCOHOLIC PURE STEATOSIS AND STEATOHEPATITIS: A NATIONWIDE BIOPSY- AND REGISTRY-BASED STUDY

     Article • Journal of Hepatology, April 2012, Elsevier

     Clinical Chair Professor Henning Gronbaek

357. 
     723 SOLUBLE CD163, A MARKER FOR MACROPHAGE ACTIVATION, IS NOT ASSOCIATED TO HCC, PER SE BUT PREDICTS DISEASE PROGRESSION

     Article • Journal of Hepatology, April 2012, Elsevier

     Clinical Chair Professor Henning Gronbaek

358. 
     Carvedilol or propranolol in portal hypertension? A randomized comparison

     Article • Scandinavian Journal of Gastroenterology, March 2012, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

359. 
     Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition

     Article • British Journal of Cancer, February 2012, Nature

     Clinical Chair Professor Henning Gronbaek, Francesca Crowe

360. 
     Effect of a 10-week Weight Loss Camp on Fatty Liver Disease and Insulin Sensitivity in Obese Danish Children

     Article • Journal of Pediatric Gastroenterology and Nutrition, February 2012, Wolters Kluwer Health

     Clinical Chair Professor Henning Gronbaek

361. 
     Effects of long-acting somatostatin analogues on adrenal growth and phosphoribosyl pyrophosphate formation in experimental diabetes

     Article • International Journal of Experimental Pathology, January 2012, Wiley

     Clinical Chair Professor Henning Gronbaek

362. 
     Incidence and Survival of Patients with Small Intestinal Neuroendocrine Tumours in a Danish NET Center

     Article • The Scientific World JOURNAL, January 2012, Hindawi Publishing Corporation

     Clinical Chair Professor Henning Gronbaek

363. 
     Goblet Cell Carcinoid in a Patient with Neurofibromatosis Type 1: A Rare Combination

     Article • Case Reports in Gastrointestinal Medicine, January 2012, Hindawi Publishing Corporation

     Clinical Chair Professor Henning Gronbaek, Tine Gregersen

364. 
     Prognosis and staging of non-alcoholic fatty liver disease

     Article • BMJ, November 2011, BMJ

     Clinical Chair Professor Henning Gronbaek

365. 
     Effects of Sandostatin LAR on gastrointestinal motility in patients with neuroendocrine tumors

     Article • Scandinavian Journal of Gastroenterology, May 2011, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek, Tine Gregersen

366. 
     Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS

     Article • Gut, May 2011, BMJ

     Clinical Chair Professor Henning Gronbaek

367. 
     Peptide Receptor Radionuclide Therapy with 90Y-DOTATOC and 177Lu-DOTATOC in Advanced Neuroendocrine Tumors: Results from a Danish Cohort Treated in Switzerland

     Article • Neuroendocrinology, January 2011, Karger Publishers

     Professor Andreas Kjaer, Clinical Chair Professor Henning Gronbaek, Tine Gregersen

368. 
     Effects of ischemic pre- and postconditioning on HIF-1α, VEGF and TGF-β expression after warm ischemia and reperfusion in the rat liver

     Article • Comparative Hepatology, January 2011, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

369. 
     IL-6 has no acute effect on the regulation of urea synthesisin vivoin rats

     Article • Scandinavian Journal of Clinical and Laboratory Investigation, December 2010, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

370. 
     Age-dependency of galactose elimination capacity in healthy children and children with chronic liver disease

     Article • Scandinavian Journal of Gastroenterology, November 2010, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

371. 
     Expression of genes involved in rat liver angiogenesis after ischaemia and reperfusion: effects of ischaemic pre- and post-conditioning

     Article • HPB, October 2010, Elsevier

     Clinical Chair Professor Henning Gronbaek

372. 
     Creation of a Fistula Between the Hepatic Duct and the Gastric Lumen by way of Percutaneus Transhepatic Cholangiography: A Case Report

     Article • Journal of Gastrointestinal Cancer, September 2010, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

373. 
     Effect of weight reduction on insulin sensitivity, sex hormone-binding globulin, sex hormones and gonadotrophins in obese children

     Article • European Journal of Endocrinology, September 2010, Bioscientifica

     Clinical Chair Professor Henning Gronbaek

374. 
     A cross-sectional analysis of the associations between adult height, BMI and serum concentrations of IGF-I and IGFBP-1 -2 and -3 in the European Prospective Investigation into Cancer and Nutrition (EPIC)

     Article • Annals of Human Biology, August 2010, Taylor & Francis

     Dr Inger T. Gram, Clinical Chair Professor Henning Gronbaek, Francesca Crowe

375. 
     Unchanged capacity of urea synthesis during acute phase response in rats

     Article • European Journal of Clinical Investigation, August 2010, Wiley

     Clinical Chair Professor Henning Gronbaek

376. 
     Insulin sensitivity and body composition in cirrhosis: changes after TIPS

     Article • AJP Gastrointestinal and Liver Physiology, August 2010, American Physiological Society

     Clinical Chair Professor Henning Gronbaek

377. 
     Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours

     Article • Acta Oncologica, June 2010, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

378. 
     Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies

     Article • The Lancet Oncology, June 2010, Elsevier

     Clinical Chair Professor Henning Gronbaek

379. 
     Ascites from patients with alcoholic liver cirrhosis contains higher IGF-I bioactivity than serum

     Article • Clinical Endocrinology, May 2010, Wiley

     Clinical Chair Professor Henning Gronbaek

380. 
     169 CARVEDILOL OR PROPRANOLOL IN PORTAL HYPERTENSION? A RANDOMIZED CLINICAL TRIAL

     Article • Journal of Hepatology, April 2010, Elsevier

     Clinical Chair Professor Henning Gronbaek

381. 
     514 CIRCULATING SCD163, A SCAVENGER RECEPTOR RELEASED FROM ACTIVATED MACROPHAGES, IS ASSOCIATED WITH PORTAL HYPERTENSION IN PATIENTS WITH LIVER CIRRHOSIS

     Article • Journal of Hepatology, April 2010, Elsevier

     Clinical Chair Professor Henning Gronbaek

382. 
     586 IMAGING OF NEUROENDOCRINE TUMORS AND LIVER METASTASIS BY F18-DOPA PET SCANNING

     Article • Journal of Hepatology, April 2010, Elsevier

     Clinical Chair Professor Henning Gronbaek

383. 
     Serum levels of IGF‐I, IGFBP‐3 and colorectal cancer risk: results from the EPIC cohort, plus a meta‐analysis of prospective studies

     Article • International Journal of Cancer, January 2010, Wiley

     Dr Inger T. Gram, Clinical Chair Professor Henning Gronbaek

384. 
     Body composition changes after transjugular intrahepatic portosystemic shunt in patients with cirrhosis

     Article • World Journal of Gastroenterology, January 2010, Baishideng Publishing Group Co., Limited (formerly WJG Press)

     Jonathan Montomoli, Clinical Chair Professor Henning Gronbaek

385. 
     Tumor necrosis factor-α acutely up-regulates urea synthesisin vivoin rats – a hepatic component of inflammatory catabolism?

     Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 2010, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

386. 
     Partial Liver Ischemia Is Followed by Metabolic Changes in the Normally Perfused Part of the Liver during Reperfusion

     Article • European Surgical Research, January 2010, Karger Publishers

     Clinical Chair Professor Henning Gronbaek

387. 
     Soluble membrane attack complex in ascites in patients with liver cirrhosis without infections

     Article • World Journal of Hepatology, January 2010, Baishideng Publishing Group Co., Limited (formerly WJG Press)

     Clinical Chair Professor Henning Gronbaek

388. 
     Growth hormone and growth hormone secretagogue effects on nitrogen balance and urea synthesis in steroid treated rats

     Article • Growth Hormone & IGF Research, October 2009, Elsevier

     Clinical Chair Professor Henning Gronbaek

389. 
     The Association between Diet and Serum Concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition

     Article • Cancer Epidemiology Biomarkers & Prevention, May 2009, American Association for Cancer Research (AACR)

     Clinical Chair Professor Henning Gronbaek, Francesca Crowe

390. 
     752 EFFECT OF TIPS ON SOLUBLE CD163 IN PATIENTS WITH LIVER CIRRHOSIS

     Article • Journal of Hepatology, April 2009, Elsevier

     Clinical Chair Professor Henning Gronbaek

391. 
     159 EFFECTS OF ISCHEMIC PRE- AND POSTCONDITIONING ON HIF-1α, VEGF AND TGF-β EXPRESSION DURING WARM LIVER ISCHEMIA AND REPERFUSION

     Article • Journal of Hepatology, April 2009, Elsevier

     Clinical Chair Professor Henning Gronbaek

392. 
     194 INSULIN SENSITIVITY AND BODY COMPOSITION IN CIRRHOSIS: CHANGES AFTER TIPS

     Article • Journal of Hepatology, April 2009, Elsevier

     Clinical Chair Professor Henning Gronbaek

393. 
     99 RISK OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH LIVER DISEASE: A NATIONWIDE POPULATION- BASED CASE-CONTROL STUDY

     Article • Journal of Hepatology, April 2009, Elsevier

     Clinical Chair Professor Henning Gronbaek

394. 
     252 TUMOR NECROSIS FACTOR-ALPHA ACUTELY UP-REGULATES UREA SYNTHESIS IN VIVO IN RATS – A HEPATIC ELEMENT OF INFLAMMATORY CATABOLISM

     Article • Journal of Hepatology, April 2009, Elsevier

     Clinical Chair Professor Henning Gronbaek

395. 
     The IGF system after insertion of a transjugular intrahepatic porto-systemic shunt in patients with liver cirrhosis

     Article • European Journal of Endocrinology, March 2009, Bioscientifica

     Clinical Chair Professor Henning Gronbaek

396. 
     Cytokine Changes during Warm Ischemia and Reperfusion of the Pig Liver with or without Preconditioning

     Article • European Surgical Research, March 2009, Karger Publishers

     Clinical Chair Professor Henning Gronbaek

397. 
     Risk of Venous Thromboembolism in Patients With Liver Disease: A Nationwide Population-Based Case–Control Study

     Article • The American Journal of Gastroenterology, January 2009, Nature

     Clinical Chair Professor Henning Gronbaek

398. 
     The influence of preconditioning on metabolic changes in the pig liver before, during, and after warm liver ischemia measured by microdialysis

     Article • Hepatology International, October 2008, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

399. 
     Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes

     Article • Expert Review of Gastroenterology & Hepatology, October 2008, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

400. 
     sMAC in plasma and ascites from patients with liver cirrhosis

     Article • Molecular Immunology, October 2008, Elsevier

     Clinical Chair Professor Henning Gronbaek

401. 
     Liver cirrhosis, other liver diseases, and risk of hospitalisation for intracerebral haemorrhage: A Danish population-based case-control study

     Article • BMC Gastroenterology, May 2008, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

402. 
     Soluble CD163 from activated macrophages predicts mortality in acute liver failure

     Article • Journal of Hepatology, November 2007, Elsevier

     Clinical Chair Professor Henning Gronbaek

403. 
     Metabolic Changes in the Pigliver During Warm Ischemia and Reperfusion Measured by Microdialysis

     Article • Journal of Gastrointestinal Surgery, October 2007, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

404. 
     3530 POSTER Preliminary results from GEPTOSIS, the international study on medical treatment practice and outcomes in gastroenteropancreatic (GEP) neuroendocrine tumors (NET): variability in the time between initial diagnosis and treatment of GEP NET

     Article • European Journal of Cancer Supplements, September 2007, Elsevier

     Clinical Chair Professor Henning Gronbaek

405. 
     Portal vein thrombosis; risk factors, clinical presentation and treatment

     Article • BMC Gastroenterology, August 2007, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

406. 
     Serum Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein-3 Concentrations and Prostate Cancer Risk: Results from the European Prospective Investigation into Cancer and Nutrition

     Article • Cancer Epidemiology Biomarkers & Prevention, June 2007, American Association for Cancer Research (AACR)

     Clinical Chair Professor Henning Gronbaek

407. 
     Impact of Enteral Supplements Enriched with ω–3 Fatty Acids and/or ω–6 Fatty Acids, Arginine and Ribonucleic Acid Compounds on Leptin Levels and Nutritional Status in Active Crohn’s Disease Treated with Prednisolone

     Article • Digestion, April 2007, Karger Publishers

     Clinical Chair Professor Henning Gronbaek

408. 
     Opposite effects on regulation of urea synthesis by early and late uraemia in rats

     Article • Clinical Nutrition, April 2007, Elsevier

     Clinical Chair Professor Henning Gronbaek

409. 
     The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn’s disease: Relations to disease activity and corticosteroid treatment

     Article • Growth Hormone & IGF Research, February 2007, Elsevier

     Clinical Chair Professor Henning Gronbaek

410. 
     Effects of urodilatin on natriuresis in cirrhosis patients with sodium retention

     Article • BMC Gastroenterology, January 2007, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

411. 
     Effects of five different alcoholic drinks on patients with Crohn's disease

     Article • Scandinavian Journal of Gastroenterology, January 2007, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

412. 
     Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition

     Article • International Journal of Cancer, January 2007, Wiley

     Clinical Chair Professor Henning Gronbaek

413. 
     The insulin-like growth factor (IGF) system and its relation to infliximab treatment in adult patients with Crohn's disease

     Article • Scandinavian Journal of Gastroenterology, January 2007, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

414. 
     Serum Trefoil Factors in Patients with Inflammatory Bowel Disease

     Article • Digestion, November 2006, Karger Publishers

     Clinical Chair Professor Henning Gronbaek

415. 
     Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women

     Article • European Journal of Clinical Nutrition, August 2006, Nature

     Clinical Chair Professor Henning Gronbaek

416. 
     Quality improvement in wellness reports in patients with Crohn’s disease

     Article • Accreditation and Quality Assurance, June 2006, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

417. 
     Discharge diagnoses of liver diseases in Nuuk Greenland compared to a Danish county hospital

     Article • International Journal of Circumpolar Health, April 2006, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

418. 
     Associations between the IGF system and inflammatory markers in inflammatory bowel disease

     Article • Alimentary Pharmacology & Therapeutics, February 2006, Wiley

     Clinical Chair Professor Henning Gronbaek

419. 
     Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega-6 fatty acids

     Article • Alimentary Pharmacology & Therapeutics, December 2005, Wiley

     Clinical Chair Professor Henning Gronbaek

420. 
     Complement activation capacity in plasma before and during high-dose prednisolone treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis

     Article • BMC Gastroenterology, September 2005, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

421. 
     The Insulin-Like Growth Factor System and Markers of Inflammation in Adult Patients with Inflammatory Bowel Disease

     Article • Hormone Research in Paediatrics, August 2005, Karger Publishers

     Clinical Chair Professor Henning Gronbaek

422. 
     Effects of pure ethanol and alcopops on glucose, insulin, and the insulin-like growth factor system in healthy subjects

     Article • Growth Hormone & IGF Research, August 2005, Elsevier

     Clinical Chair Professor Henning Gronbaek

423. 
     Insulin-like growth factors (IGFs) and IGF binding proteins in active Crohn's disease treated with ω-3 or ω-6 fatty acids and corticosteroids

     Article • Scandinavian Journal of Gastroenterology, January 2005, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

424. 
     The Involvement of Growth Hormone (GH), Insulin-Like Growth Factors (IGFs) and Vascular Endothelial Growth Factor (VEGF) in Diabetic Kidney Disease

     Article • Current Pharmaceutical Design, October 2004, Bentham Science Publishers

     Clinical Chair Professor Henning Gronbaek

425. 
     The Influence of Amphotericin B and Neomycin on the Effect of Human Relaxin-2 on Foetal Membranes and Isolated Myometrium

     Article • Basic & Clinical Pharmacology & Toxicology, March 2004, Wiley

     Clinical Chair Professor Henning Gronbaek

426. 
     Budd‐Chiari and inferior caval vein syndromes due to membranous obstruction of the liver veins: successful treatment with angioplasty and transcaval transjugular intrahepatic porto‐systemic shunt

     Article • Scandinavian Journal of Gastroenterology, January 2004, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

427. 
     Combined liver vein and spleen pulp pressure measurements in patients with portal or splenic vein thrombosis

     Article • Scandinavian Journal of Gastroenterology, January 2004, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

428. 
     Albumin in vaginal fluid is a marker of infection in early pregnancy

     Article • International Journal of Gynecology & Obstetrics, August 2003, Wiley

     Clinical Chair Professor Henning Gronbaek

429. 
     Editorial

     Article • Synthesis, August 2003, Thieme Publishing Group

     Clinical Chair Professor Henning Gronbaek

430. 
     Effect of Combination Therapy with a Calcium Channel Blocker and an Angiotensin-Converting Enzyme Inhibitor on Renal Hypertrophy and Urinary Albumin Excretion in Diabetic Rats

     Article • Experimental Diabesity Research, January 2003, Hindawi Publishing Corporation

     Clinical Chair Professor Henning Gronbaek

431. 
     Markers of fetal growth and serum levels of insulin-like growth factor (IGF) I, -II and IGF binding protein 3 in adults

     Article • European Journal of Epidemiology, January 2003, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

432. 
     Inhibitory effects of octreotide on renal and glomerular growth in early experimental diabetes in mice

     Article • Journal of Endocrinology, March 2002, Bioscientifica

     Clinical Chair Professor Henning Gronbaek

433. 
     Low free and total insulinlike growth factor I (IGF-I) and IGF binding protein-3 levels in chronic inflammatory bowel disease: partial normalization during prednisolone treatment

     Article • The American Journal of Gastroenterology, March 2002, Nature

     Clinical Chair Professor Henning Gronbaek

434. 
     Effects of octreotide on serum insulin-like growth factor I and insulin-like growth factor binding proteins in patients with cirrhosis

     Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 2002, Taylor & Francis

     Clinical Chair Professor Henning Gronbaek

435. 
     Lessons Learned From Lymphocytes: CC Chemokine Receptor-7 Involved in Lymphogenic Metastasis of Melanoma

     Article • JNCI Journal of the National Cancer Institute, November 2001, Oxford University Press (OUP)

     Clinical Chair Professor Henning Gronbaek

436. 
     Signaling lymphocytic activation molecule (SLAM) regulates T cellular cytotoxicity

     Article • European Journal of Immunology, September 2001, Wiley

     Clinical Chair Professor Henning Gronbaek

437. 
     Angiotensin converting enzyme inhibitor suppresses glomerular transforming growth factor β receptor expression in experimental diabetes in rats

     Article • Diabetologia, April 2001, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

438. 
     Inhibition of Major Histocompatibility Complex Class II-Dependent Antigen Presentation by Neutralization of Gamma Interferon Leads to Breakdown of Resistance against Measles Virus-Induced Encephalitis

     Article • Journal of Virology, April 2001, ASM Journals

     Clinical Chair Professor Henning Gronbaek

439. 
     Comparison of the effects of nitrendipine and enalapril on development and progression of diabetic glomerulopathy in streptozotocin-diabetic rats

     Article • Diabetes Research and Clinical Practice, September 2000, Elsevier

     Clinical Chair Professor Henning Gronbaek

440. 
     Effect of nitrendipine and nisoldipine on renal structure and function in long-term experimental diabetes in rats

     Article • American Journal of Kidney Diseases, August 2000, Elsevier

     Clinical Chair Professor Henning Gronbaek

441. 
     Serum markers for hepatic fibrosis in chronic hepatitis C

     Article • Gastroenterology, April 2000, Elsevier

     Clinical Chair Professor Henning Gronbaek

442. 
     The Renal Expression of Transforming Growth Factor-  Isoforms and Their Receptors in Acute and Chronic Experimental Diabetes in Rats

     Article • Endocrinology, March 2000, Endocrine Society

     Clinical Chair Professor Henning Gronbaek

443. 
     Effect of the calcium channel blocker nitrendipine in normotensive and spontaneously hypertensive, diabetic rats on kidney morphology and urinary albumin excretion

     Article • Journal of Hypertension, July 1999, Wolters Kluwer Health

     Clinical Chair Professor Henning Gronbaek

444. 
     The Calcium Channel Blocker Nitrendipine Attenuates Renal and Glomerular Hypertrophy in Diabetic Rats

     Article • Nephron Experimental Nephrology, May 1999, Karger Publishers

     Clinical Chair Professor Henning Gronbaek

445. 
     Developmental Changes in Serum Levels of Free and Total Insulin-Like Growth Factor I (IGF-I), IGF-Binding Protein-1 and -3, and the Acid-Labile Subunit in Rats1

     Article • Endocrinology, October 1998, Endocrine Society

     Clinical Chair Professor Henning Gronbaek

446. 
     Developmental Changes in Serum Levels of Free and Total Insulin-Like Growth Factor I (IGF-I), IGF-Binding Protein-1 and -3, and the Acid-Labile Subunit in Rats

     Article • Endocrinology, October 1998, Endocrine Society

     Clinical Chair Professor Henning Gronbaek

447. 
     Effect of immunosuppression on kidney and serum insulin-like growth factor-I (IGF-I), IGF binding proteins, and renal growth following unilateral nephrectomy in rats

     Article • Metabolism, July 1998, Elsevier

     Clinical Chair Professor Henning Gronbaek

448. 
     Effects of growth hormone on steroid-induced increase in ability of urea synthesis and urea enzyme mRNA levels

     Article • AJP Endocrinology and Metabolism, July 1998, American Physiological Society

     Clinical Chair Professor Henning Gronbaek

449. 
     Octreotide prevents the early increase in renal insulin-like growth factor binding protein 1 in streptozotocin diabetic rats

     Article • Diabetes, June 1998, American Diabetes Association

     Clinical Chair Professor Henning Gronbaek

450. 
     Growth hormone administration can improve growth in glucocorticoid-injected rats without affecting the lymphocytopenic effect of the glucocorticoid

     Article • Growth Hormone & IGF Research, June 1998, Elsevier

     Clinical Chair Professor Henning Gronbaek

451. 
     Diabetic kidney disease: the role of growth factors

     Article • Nephrology Dialysis Transplantation, May 1998, Oxford University Press (OUP)

     Clinical Chair Professor Henning Gronbaek

452. 
     Herpesvirus Saimiri Transforms Human T-Cell Clones to Stable Growth without Inducing Resistance to Apoptosis

     Article • Journal of Virology, April 1998, ASM Journals

     Clinical Chair Professor Henning Gronbaek

453. 
     Differential expression of renal growth hormone receptor and its binding protein in experimental diabetes mellitus

     Article • Growth Hormone & IGF Research, February 1998, Elsevier

     Clinical Chair Professor Henning Gronbaek

454. 
     Effect of octreotide, captopril or insulin on renal changes and UAE in long-term experimental diabetes

     Article • Kidney International, January 1998, Elsevier

     Clinical Chair Professor Henning Gronbaek

455. 
     The Role of Growth Hormone, Insulin-Like Growth Factors, Epidermal Growth Factor and Transforming Growth Factor β in Diabetic Kidney Disease: An Update

     Article • January 1998, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

456. 
     Effect of GH/IGF-I deficiency on long-term renal changes and urinary albumin excretion in diabetic dwarf rats

     Article • AJP Endocrinology and Metabolism, May 1997, American Physiological Society

     Clinical Chair Professor Henning Gronbaek

457. 
     Changes in Facilitative Glucose Transporter Messenger Ribonucleic Acid Levels in the Diabetic Rat Kidney1

     Article • Endocrinology, March 1997, Endocrine Society

     Clinical Chair Professor Henning Gronbaek

458. 
     Changes in Facilitative Glucose Transporter Messenger Ribonucleic Acid Levels in the Diabetic Rat Kidney

     Article • Endocrinology, March 1997, Endocrine Society

     Clinical Chair Professor Henning Gronbaek

459. 
     Effect of graded renal ablation on kidney and serum insulin-like growth Factor-I (IGF-I) and IGF binding proteins in rats: Relation to compensatory renal growth

     Article • Metabolism, January 1997, Elsevier

     Clinical Chair Professor Henning Gronbaek

460. 
     The Role of Growth Factors in Diabetic Kidney Disease

     Article • January 1996, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

461. 
     Increased number of myocardial voltage-gated Ca2+ channels and unchanged total  -receptor number in long-term streptozotocin-diabetic rats

     Article • European Journal of Endocrinology, January 1996, Bioscientifica

     Clinical Chair Professor Henning Gronbaek

462. 
     Effect of hyperthyroidism on circulating levels of free and total IGF-I and IGFBPs in rats

     Article • AJP Endocrinology and Metabolism, November 1995, American Physiological Society

     Clinical Chair Professor Henning Gronbaek

463. 
     The role of growth hormone, insulin-like growth factors (IGFs), and IGF-binding proteins in experimental diabetic kidney disease

     Article • Metabolism, October 1995, Elsevier

     Clinical Chair Professor Henning Gronbaek

464. 
     Effect of octreotide on experimental diabetic renal and glomerular growth: importance of early intervention

     Article • Journal of Endocrinology, October 1995, Bioscientifica

     Clinical Chair Professor Henning Gronbaek

465. 
     Effect of Diabetes and Dietary Ubiquinone Supplementation on the Post-translational Modification of Rat Lens βL Crystallin

     Article • Biochemical and Molecular Medicine, August 1995, Elsevier

     Clinical Chair Professor Henning Gronbaek

466. 
     Expression of insulin-like growth factor binding proteins in the rat kidney: effects of long-term diabetes.

     Article • Endocrinology, May 1995, Endocrine Society

     Clinical Chair Professor Henning Gronbaek

467. 
     Expression of insulin-like growth factor binding proteins in the rat kidney: effects of long-term diabetes

     Article • Endocrinology, May 1995, Endocrine Society

     Clinical Chair Professor Henning Gronbaek

468. 
     Effect of sodium selenite on growth, insulin-like growth factor-binding proteins and insulin-like growth factor-I in rats

     Article • Journal of Endocrinology, April 1995, Bioscientifica

     Clinical Chair Professor Henning Gronbaek

469. 
     Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats

     Article • Diabetologia, February 1995, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

470. 
     Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats

     Article • Diabetologia, January 1995, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

471. 
     Lanreotide, a somatostatin analogue, reduces insulin-like growth factor I accumulation in proliferating aortic tissue in rabbits in vivo. A preliminary study

     Article • European Journal of Endocrinology, April 1994, Bioscientifica

     Clinical Chair Professor Henning Gronbaek

472. 
     Roles of Growth Factors in Diabetic Kidney Disease

     Article • January 1994, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

473. 
     Selenium in the central nervous system of rats exposed to 75-Sel-selenomethionine and sodium selenite

     Article • Biological Trace Element Research, November 1992, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek

474. 
     Increased ornithine decarboxylase activity in kidneys undergoing hypertrophy in experimental diabetes

     Article • Molecular and Cellular Endocrinology, July 1992, Elsevier

     Clinical Chair Professor Henning Gronbaek, Steen B. Pedersen

475. 
     Selenium complexes in the anterior pituitary of rats exposed to L-selenomethionine

     Article • Virchows Archiv B Cell Pathology Including Molecular Pathology, December 1990, Springer Science + Business Media

     Clinical Chair Professor Henning Gronbaek